US Patent Issued to The Administrators of the Tulane Educational Fund, NATIONAL INSTITUTES OF HEALTH (NIH), U.S DEPT OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT on April 21 for "CRISPR-based compositions for treating vascular disorders" (Louisiana Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,398, issued on April 21, was assigned to The Administrators of the Tulane Educational Fund (New Orleans) and NATIONAL INSTITUTES OF HEALTH (NIH), U.S DEPT OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (Bethesda, Md.).

"CRISPR-based compositions for treating vascular disorders" was invented by Shusheng Wang (New Orleans) and Bo Yu (New Orleans).

According to the abstract* released by the U.S. Patent & Trademark Office: "CRISPR-based compositions and methods of their use to impair or promote angiogenesis in a patient to treat indications including, but not limited to, tumor growth, age-related macular degeneration, and metastasis. Single-guide ribonucleic acids sg-RNA-1 (SE...